Cairo Pharmaceuticals News - Mubasher Info
KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
16 January 07:38 AM

Cairo Pharmaceuticals (CPCI)

Last update: 15 January 02:14 PM market time.
264.48
-0.19
-0.07%
Open 264.69
Previous Close 264.69
High 268.00
Low 261.00
Stock Statistics
Volume 4,928
Turnover 1,305,797.00
All data are 15 minutes late during market session

News

Photo Archive
15 February 2022 00:33 AM Kahira Pharmaceuticals' net profits up 22.5% in H1-21/22
Cairo – Mubasher: Kahira Pharmaceuticals posted a 22.47% year-on-year (YoY) increase in profits after tax during the first half (H1) of fiscal year (FY) 2021/2022. Net profits amounted to EGP 82.05 million in the six-month period that ended on 31 …
Financial Results
Photo Archive
26 January 2022 03:15 PM Kahira Pharmaceuticals sees EGP 9m block trading deal
Cairo – Mubasher: The Egyptian Exchange (EGX) has announced a block trading deal worth EGP 9.24 million on the shares of Kahira Pharmaceuticals. The block trading deal was implemented on 255,544 of Kahira's shares, according to a bourse filing on …
Companies Investments
The company also named Yasser Ahmed Farghaly as the Managing Director
6 June 2021 05:48 PM Adel Taha Abdel Wahab named Chairman of Kahira Pharmaceuticals
Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the appointment of Adel Taha Abdel Wahab as the company’s Chairman. The company also named Yasser Ahmed Farghaly as the Managing Director, according to a bourse disclosure …
Board of Directors
The sales grew to EGP 805.87 million in the period ended 31 March
5 May 2021 02:45 PM Kahira Pharmaceuticals posts 12% higher profit in nine months
Cairo – Mubasher: Kahira Pharmaceuticals achieved net profits of EGP 102.9 million in the first nine months of fiscal year (FY) 2020/2021, up by 11.6% year-on-year (YoY) from EGP 92.23 million, the unaudited financial results showed. The sales …
Financial Results
The proposed investments amount to EGP 37.76 million in the coming fiscal year
16 February 2021 11:44 AM Kahira Pharmaceuticals targets EGP 145m profit in FY21/22
Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the planned budget for fiscal year 2021/2022. The company aims to achieve profits of EGP 145.08 million in the coming fiscal year, compared to an expected profit of EGP …
Financial Results
Kahira Pharmaceuticals jumped by 32% in three months
20 October 2020 05:09 PM Pharma stocks lead EGX ahead of potential acquisitions
Cairo – Mubasher: Amid market volatility due to concerns over a second wave of coronavirus (COVID-19) infections, pharmaceutical stocks on the Egyptian Exchange (EGX) reported strong performance ahead of potential mergers and acquisitions. Amr …
Trading Activities
The company achieved sales of EGP 1.01 billion
30 August 2020 06:01 PM Kahira Pharmaceuticals sees 28% profit rise in FY19/20
Cairo – Mubasher: The net profits of Kahira Pharmaceuticals grew by 28.14% year-on-year (YoY) to EGP 109.14 million in fiscal year 2019/2020 from EGP 85.17 million. Sales increased to EGP 1.01 billion in the year ended 30 June, compared to EGP …
Financial Results
company’s sales rose to EGP 1 billion
10 August 2020 04:12 PM Kahira Pharmaceuticals posts 34% profit growth in FY19/20 initial results
Cairo – Mubasher: Kahira Pharmaceuticals reported net profits of EGP 113.8 million in fiscal year 2019/2020, up by 33.6% year-on-year (YoY) from EGP 85.17 million, the company's unaudited financial results showed. The company’s sales rose to EGP 1 …
Financial Results
The company’s net profits rose to EGP 92.22 million
13 May 2020 02:38 PM Kahira Pharmaceuticals reports 28% profit rise in 9M
Cairo – Mubasher: The unaudited financial results of Kahira Pharmaceuticals showed a 27.7% year-on-year (YoY) profit growth during the first nine months of fiscal year 2019/2020. The company’s net profits rose to EGP 92.22 million in the …
Financial Results
Sales grew to EGP 513.16 million in H1 of FY19/20
10 February 2020 01:03 PM Kahira Pharmaceuticals posts 29% profit hike in H1-19/20 unaudited financials
Cairo – Mubasher: The unaudited financial results of Kahira Pharmaceuticals showed a 29.3% year-on-year profit surge during the first half of fiscal year 2019/2020. Net profits amounted to EGP 56.77 million in the six-month period ended 31 …
Financial Results
Sales retreated to EGP 247.8 million
13 November 2019 11:02 AM Kahira Pharmaceuticals’ profit down 18% in Q1-19/20 unaudited financials
Cairo – Mubasher: The unaudited financial results of Kahira Pharmaceuticals reported a 17.66% year-on-year profit decline during the first quarter of fiscal year 2019/2020. Net profits slid to EGP 25.72 million from July 2018 to last June, …
Financial Results
A cash dividend of EGP 2.5 per share was approved
29 September 2019 01:32 PM Kahira Pharmaceuticals approves dividends, bonus shares for FY18/19
Cairo – Mubasher: Kahira Pharmaceuticals announced that its shareholders approved distributing cash dividends and bonus shares for fiscal year 2018/2019 during an ordinary general meeting (OGM). The pharmaceuticals firm approved distributing a …
Cash Dividends
Cost of sales grew to EGP 733.3 million
29 August 2019 02:22 PM Kahira Pharmaceuticals posts 21% profit drop in FY18/19
Cairo – Mubasher: Kahira Pharmaceuticals reported a 21.4% year-on-year profit decline during fiscal year 2018/2019, pressured by higher cost of sales. Net profits plunged to EGP 85.17 million from July 2018 to last June, compared to EGP 108.45 …
Financial Results
Net profit amounted to EGP 72.2m in the nine-month period ended last March
6 May 2019 09:59 AM Kahira Pharmaceuticals reports 10% profit decline in 9M
Cairo – Mubasher: Kahira Pharmaceuticals has posted a 9.8% year-on-year decrease in its profits for the first nine months of fiscal year 2018/2019. Net profit amounted to EGP 72.2 million in the nine-month period ended in March, versus EGP 80.02 …
Financial Results
Kahira Pharmaceuticals on Wednesday posted a 91% year-on-year hike in profits for fiscal year 2016/2017
2 August 2017 11:23 AM Kahira Pharmaceuticals profits surge 91% in FY16/17
Cairo – Mubasher: Kahira Pharmaceuticals on Wednesday posted a 91% year-on-year hike in profits for fiscal year 2016/2017 due to higher sales and foreign exchange gains, according to a bourse filing. The Egyptian firm achieved profits of EGP 97.8 …
Financial Results
Photo Credit: Arabianeye-Reuters
22 May 2017 05:40 PM Kahira Pharmaceuticals to produce Brufen for Abbott
Cairo - Mubasher: Kahira Pharmaceuticals said that Abbott Laboratories has supplied a new assembly line to produce Brufen syrup at its own cost. The company said in a statement to the Egyptian Exchange (EGX) on Monday that the product will be sold …
Companies Investments
(Photo credit: Arabianeye - Reuters)
7 May 2017 11:54 AM Kahira Pharmaceuticals profits rise 118% in 9M
Cairo – Mubasher: Kahira Pharmaceuticals on Sunday posted a year-on-year increase of 117.9% in net profits for the first nine months of fiscal year 2016/2017. Net profits for the first nine months of FY16/17 reached EGP 71.9 million, compared to …
Financial Results
(Photo credit: Arabianeye - Reuters)
29 March 2017 11:11 AM Kahira Pharmaceuticals OGM approves FY17/18 budget draft
Cairo – Mubasher: Kahira Pharmaceuticals said Wednesday that its ordinary general meeting (OGM) has adopted the estimated budget draft and the investment plan for fiscal year 2017/2018, according to a bourse filing. Earlier this month, the company …
General Assembly
Photo Credit: Arabianeye-Reuters
26 March 2017 06:10 PM Pharos recommends Overweight on Cairo Pharmaceuticals
Cairo - Mubasher: Pharos research has assigned Cairo Pharmaceuticals Company (CPCI) an Overweight recommendation with a fair value (FV) of EGP 36.16. The company’s stock is trading at much cheaper than its peer group average, Pharos said in a …
Ratings
(Photo credit: Arabianeye - Reuters)
12 March 2017 00:37 PM Kahira Pharmaceuticals targets EGP 89m profits in 2017/18
Cairo – Mubasher: Kahira Pharmaceuticals said Sunday that it seeks to achieve an increase of 83.1% in its profits for fiscal year 2017/2018 to EGP 88.5 million, versus an estimated profit worth EGP 48.3 million for FY16/17. Revenues are targeted …
Financial Results
Profits increased 85.5% in the first half of fiscal 2016/17 (Photo Credit: Arabianeye-Reuters)
15 February 2017 11:07 AM Kahira Pharmaceuticals Q2 profits up 97%
Cairo – Mubasher: Kahira Pharmaceuticals posted on Wednesday a rise of 96.7% in the company’s profits for the second quarter of fiscal 2016-2017 to EGP 28.5 million, versus EGP 14.49 million for fiscal 2015/16. In the first half of fiscal 2016/17, …
Financial Results
Profits excluding FX gains totalled EGP 43.35 million in H1 - (Photo Credit: Arabianeye-Reuters)
7 February 2017 03:33 PM Kahira Pharmaceuticals profits up 77% in Q2
Cairo - Mubasher: Kahira Pharmaceuticals reported an increase in profits in the second quarter of fiscal year 2016-2017 by 76.533%, as shown by the company’s financial statements. According to the company’s statement to the Egyptian Exchange (EGX) …
Financial Results
he company registered EGP 17.77 million profits in Q1 - Photo Credit: Reuters
9 November 2016 01:57 PM Kahira Pharmaceuticals profits up 69% in Q1
Cairo – Mubasher: Kahira Pharmaceuticals reported a 69.3% profit increase during the first quarter of 2016/17, according to a bourse filing. The company registered EGP 17.77 million profits in Q1, compared with EGP 10.5 million profits for the …
Financial Results
The company is capitalized at EGP 119.47 million - Photo Credit: Reuters
5 October 2016 04:08 PM Record date for Arab Pharmaceuticals’ dividends 19 Oct.
Cairo – Mubasher: Arab Pharmaceuticals said Wednesday that shareholders of record till 19 October would be entitled to FY15/16 cash dividends, according to a bourse filing. The company decided to pay out EGP 1.65 per share for the fiscal year. The …
Cash Dividends
The sock quote closed at EGP 19 on last Thursday - Photo Credit: Reuters
25 September 2016 11:02 AM Kahira Pharmaceuticals nods for EGP 1.65/shr dividends
Cairo – Mubasher: Kahira Pharmaceuticals' ordinary general meeting (OGM) agreed on distributing EGP 1.65 per share as cash dividends for the fiscal year 2015/16, according to a bourse filing on Sunday. In 2015/16, the company earned EGP 51.3 …
General Assembly